Robinin attenuates cardiac hypertrophy in pulmonary heart disease by modulating SIRT1/NF-κB signaling and inhibiting oxidative stress and the NLRP3 inflammasome

Human and Experimental Toxicology · Published 2025-07-18 · DOI 10.1177/09603271251361892

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/09603271251361892

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles